UPC_APP_68369/2024

ANALYTE SENSOR AND APPARATUS FOR INSERTION OF THE SENSOR

Prozessuale & UnteranträgeRücknahmeanträgeNordic-Baltic RDApplication Rop 265—Vergleich erfolgt: Vor Hauptsache

Übersicht Entscheidungen Dokumente Zeitverlauf

Parteien

Kläger

Abbott Diabetes Care Inc.(Abbott Group)

Vertreter: Wim Maas

Beklagte

Dexcom Inc.(Dexcom Group)
Dexcom International Limited(Dexcom Group)

Vertreter: Tjibbe Douma

Richter

Stefan JohanssonPresiding Judge
Kai HärmandJudge-Rapporteur
Pierluigi PerrottiLegally Qualified Judge
Renaud FulconisTechnically Qualified Judge

Patente

EP 3 977 921

CPC-Codes: A61B5/14865, A61B2560/0475, A61B5/72, A61B5/6898, H04L67/12, A61M2205/33, C12Q1/001, A61B2560/0487, A61B5/14503, A61B5/6849, A61M5/158, A61B5/0004…

Sektor: Biotechnology

Ausgang

Zurückgenommen

Eingereicht: —

Erste Entscheidung: 20. Jan. 2025

Sprache: —

Vergleich erfolgt: Vor Hauptsache — settled commercially

The Nordic-Baltic Regional Division permitted the withdrawal of Abbott Diabetes Care Inc.'s infringement action (ACT_588346/2023) and Dexcom's counterclaim for revocation (CC_14848/2024) in Abbott v Dexcom proceedings (UPC 430/2023, EP 3 977 921). Both parties consented to each other's withdrawals and agreed that no costs order would be made. The Court declared the proceedings closed.